@maxjaderberg @MilesCcc @AndrewE_Dunn Sign up now: https://t.co/m2Z329hdl8 ...

Event Details - Isomorphic Labs 的两位高管 Max Jaderberg (Chief AI Officer) 和 MilesCcc (Chief Scientific Officer) 将于 2026 年 10 月 14 日参加 Endpoints AI Day 的炉边谈话 [1] - 炉边谈话时间为美国东部时间上午 11:00 至 11:40，共计 40 分钟 [1] Focus of Discussion - Isomorphic Labs 将深入探讨 AI 如何与药物发现相结合 [1] - Isomorphic Labs 的药物设计引擎使其能够在多个治疗领域和药物模式中运营 [1]

@SergeiIakhnin @BioTechX_ Find out more: https://t.co/4rOADZjcHx ...

In less than a week, our CTO @SergeiIakhnin will open @BioTechX_ EU with his keynote: "AI Models from Atoms to Humans: the Era of Rational In Silico Drug Design."Join him in Basel on October 6th, at 9am CEST to explore how advanced AI is already reinventing drug discovery, and his vision for a future where it accelerates breakthroughs that move us closer to solving all disease. ...

Last week, our Chief Scientific Officer @MilesCcc participated in @BioCentury Grand Rounds Europe in Cambridge, UK. During his "Small Compounds, Big Potential" panel, Miles discussed how technology is accelerating and reducing the cost of molecule creation, and the collaborative efforts of academia, start-ups, and industry in advancing drug development. ...

Event Announcement - The company's Chief Technology Officer, Sergei Iakhnin, will be a keynote speaker at BioTechX EU Congress on October 6th at 9am CEST [1] - The keynote will focus on the application of AI in understanding and solving diseases [1] AI & Biotechnology - The company aims to use AI to accelerate breakthroughs in disease research [1] - The company envisions a future where AI can help solve all diseases [1]

Drug Development & AI - Isomorphic Labs is using AI models to tackle challenging diseases, including cancers [1] - The company has a generalisable drug design engine to tackle a range of different cancers [1] Company Strategy - Isomorphic Labs aims to tackle multiple cancers rather than focusing on one program at a time [1]

General Information - The document provides a link to a resource, potentially a video or webpage [1]

Drug Discovery Timeline - Isomorphic Labs的目标是将药物发现的时间从几年缩短到几个月，甚至更快[1][2] - Demis Hassabis认为，随着Isomorphic Labs的平台在未来几年内成熟，这一目标是可能实现的[1] AI's Role in Drug Discovery - AI技术的进步可能将药物发现的时间大大缩短[2] - Isomorphic Labs正在利用统一的药物设计引擎，加速药物开发，并寻找解决世界最具挑战性疾病的方法[1] Isomorphic Labs' Mission - Isomorphic Labs的使命是利用AI技术攻克癌症[2] - Isomorphic Labs致力于更快地将药物送到患者手中[1]

Company Focus - DeepMind is leveraging frontier AI to reimagine drug discovery and advance human health [1] - DeepMind's Iso project aims to solve all diseases [1] Leadership Engagement - DeepMind's CEO, Chief AI Officer, and Head of Medicinal Drug Design were featured on Bloomberg Tech Europe to discuss AI in drug discovery [1]